The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
PsychData is an online platform for hosting and conducting surveys and experiments in psychology, supporting secure data collection for researchers and students.
The Dana Foundation is a private philanthropy that explores the connections between neuroscience and society's challenges and opportunities.
The School of Psychology at the University of Birmingham is renowned for developing graduates' knowledge and skills and for research that impacts individuals, communities, and societies.